James Sampson

660 total citations
12 papers, 500 citations indexed

About

James Sampson is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, James Sampson has authored 12 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Epidemiology. Recurrent topics in James Sampson's work include HIV/AIDS drug development and treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV Research and Treatment (4 papers). James Sampson is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV Research and Treatment (4 papers). James Sampson collaborates with scholars based in United States, Australia and Denmark. James Sampson's co-authors include David L. Cohn, Donald I. Abrams, Norman Markowitz, Evelyn J. Fisher, Beverly Alston, Roberta Luskin‐Hawk, Carol Brosgart, Melanie Thompson, Lydia Estanislao and Stephen J. Brown and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Oncogene.

In The Last Decade

James Sampson

12 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Sampson United States	9	234	158	144	101	65	12	500
Yiannis Bassiakos Greece	11	177 0.8×	130 0.8×	148 1.0×	42 0.4×	21 0.3×	19	507
D. Thorborn United Kingdom	7	271 1.2×	169 1.1×	136 0.9×	64 0.6×	62 1.0×	15	1.4k
Alastair Benbow United Kingdom	4	249 1.1×	156 1.0×	118 0.8×	61 0.6×	52 0.8×	6	1.2k
E. Jägel-Guedes Germany	3	251 1.1×	156 1.0×	119 0.8×	67 0.7×	52 0.8×	6	1.2k
О. А. Козырев Russia	2	249 1.1×	155 1.0×	116 0.8×	61 0.6×	52 0.8×	7	1.2k
A. Castley Australia	5	263 1.1×	217 1.4×	114 0.8×	53 0.5×	17 0.3×	8	1.1k
Christiansen Ft Australia	4	226 1.0×	165 1.0×	99 0.7×	48 0.5×	17 0.3×	6	1.1k
Rosa F. Yeh United States	12	348 1.5×	166 1.1×	135 0.9×	62 0.6×	11 0.2×	25	682
Keith Nieforth United States	16	214 0.9×	120 0.8×	249 1.7×	20 0.2×	24 0.4×	31	792
A. L. Sánchez Martinez United States	7	311 1.3×	364 2.3×	180 1.3×	105 1.0×	45 0.7×	7	678

Countries citing papers authored by James Sampson

Since Specialization

Citations

This map shows the geographic impact of James Sampson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Sampson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Sampson more than expected).

Fields of papers citing papers by James Sampson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Sampson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Sampson. The network helps show where James Sampson may publish in the future.

Co-authorship network of co-authors of James Sampson

This figure shows the co-authorship network connecting the top 25 collaborators of James Sampson. A scholar is included among the top collaborators of James Sampson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Sampson. James Sampson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Sarkar, Mrinmoy, James Sampson, Yava Jones‐Hall, et al.. (2025). LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway. Oncogene. 44(46). 4491–4504. 1 indexed citations

Humphries, Matthew P., Stephen McQuaid, Stephanie G. Craig, et al.. (2018). Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities. Journal of Thoracic Oncology. 14(1). 45–53. 47 indexed citations

Lifson, Alan R., Waldo Belloso, Richard T. Davey, et al.. (2010). Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials. HIV Clinical Trials. 11(4). 205–219. 35 indexed citations

Lifson, Alan R., Waldo Belloso, Richard T. Davey, et al.. (2008). Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials. HIV Clinical Trials. 9(3). 177–185. 44 indexed citations

Simpson, David M., Lydia Estanislao, Stephen J. Brown, & James Sampson. (2007). An Open-Label Pilot Study of High-Concentration Capsaicin Patch in Painful HIV Neuropathy. Journal of Pain and Symptom Management. 35(3). 299–306. 42 indexed citations

Abrams, Donald I., Judith D. Bebchuk, Eileen Denning, et al.. (2002). Randomized, Open-Label Study of the Impact of Two Doses of Subcutaneous Recombinant Interleukin-2 on Viral Burden in Patients With HIV-1 Infection and CD4+ Cell Counts of ≥300/mm3: CPCRA 059. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(3). 221–231. 37 indexed citations

Fisher, Evelyn J., Kathryn Chaloner, David L. Cohn, et al.. (2001). The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial. AIDS. 15(13). 1695–1700. 76 indexed citations

Rhame, Frank S., Richard W. Price, David C. Perlman, et al.. (1998). Experience with a cross-study endpoint review committee for AIDS clinical trials. AIDS. 12(15). 1983–1990. 16 indexed citations

Brosgart, Carol, Thomas A. Louis, David W. Hillman, et al.. (1998). A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. AIDS. 12(3). 269–277. 44 indexed citations

10.

Torres, Ramón A., James D. Neaton, Deborah Wentworth, et al.. (1998). Acyclovir Use and Survival Among Human Immunodeficiency Virus‐Infected Patients with CD4 Cell Counts of < 500/mm. Clinical Infectious Diseases. 26(1). 85–90. 3 indexed citations

11.

Abrams, Donald I., Anne I. Goldman, Cynthia A. Launer, et al.. (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 330(10). 657–662. 150 indexed citations

12.

Levinson, Wendy, Patrick M. Dunn, Thomas G. Cooney, & James Sampson. (1986). Parasitic infections in asymptomatic homosexual men. Journal of General Internal Medicine. 1(3). 150–154. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact